Clinical Trial Update: Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study [Phase 3]

View source ↗

Summary

An update on a Phase 3 pilot trial evaluating minocycline for lung scarring in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: UNKNOWN